Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection Z Miao, S Zhang, X Ou, S Li, Z Ma, W Wang, MP Peppelenbosch, J Liu, ... The Journal of infectious diseases 221 (10), 1677-1687, 2020 | 276 | 2020 |
Transcriptional regulation of antiviral interferon-stimulated genes W Wang, L Xu, J Su, MP Peppelenbosch, Q Pan Trends in microbiology 25 (7), 573-584, 2017 | 187 | 2017 |
The global burden of hepatitis E outbreaks: a systematic review MS Hakim, W Wang, WM Bramer, J Geng, F Huang, RA de Man, ... Liver International 37 (1), 19-31, 2017 | 127 | 2017 |
Hepatitis E virus infects neurons and brains X Zhou, F Huang, L Xu, Z Lin, FMS de Vrij, AC Ayo-Martin, ... The Journal of infectious diseases 215 (8), 1197-1206, 2017 | 125 | 2017 |
RIG‐I is a key antiviral interferon‐stimulated gene against hepatitis E virus regardless of interferon production L Xu, W Wang, Y Li, X Zhou, Y Yin, Y Wang, RA de Man, ... Hepatology 65 (6), 1823-1839, 2017 | 86 | 2017 |
Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections W Wang, Y Yin, L Xu, J Su, F Huang, Y Wang, PPC Boor, K Chen, ... Science signaling 10 (476), eaah4248, 2017 | 83 | 2017 |
Cross talk between nucleotide synthesis pathways with cellular immunity in constraining hepatitis E virus replication Y Wang, W Wang, L Xu, X Zhou, E Shokrollahi, K Felczak, ... Antimicrobial agents and chemotherapy 60 (5), 2834-2848, 2016 | 83 | 2016 |
Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV W Wang, L Xu, JH Brandsma, Y Wang, MS Hakim, X Zhou, Y Yin, ... Scientific reports 6 (1), 25482, 2016 | 77 | 2016 |
LGR5 marks targetable tumor-initiating cells in mouse liver cancer W Cao, M Li, J Liu, S Zhang, L Noordam, MMA Verstegen, L Wang, B Ma, ... Nature communications 11 (1), 1961, 2020 | 73 | 2020 |
SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma PY Hernanda, K Chen, AM Das, K Sideras, W Wang, J Li, W Cao, ... Oncogene 34 (39), 5055-5068, 2015 | 71 | 2015 |
PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target Y Yin, W Dang, X Zhou, L Xu, W Wang, W Cao, S Chen, J Su, X Cai, ... Virulence 9 (1), 83-98, 2018 | 65 | 2018 |
IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN‐stimulated genes L Xu, X Zhou, W Wang, Y Wang, Y Yin, LJW van der Laan, D Sprengers, ... The FASEB Journal 30 (10), 3352-3367, 2016 | 63 | 2016 |
Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development Y Yin, Y Wang, W Dang, L Xu, J Su, X Zhou, W Wang, K Felczak, ... Antiviral research 133, 41-49, 2016 | 61 | 2016 |
The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response W Wang, Y Wang, C Qu, S Wang, J Zhou, W Cao, L Xu, B Ma, MS Hakim, ... Hepatology 67 (6), 2096-2112, 2018 | 55 | 2018 |
Epigenome-wide association study identifies methylation sites associated with liver enzymes and hepatic steatosis J Nano, M Ghanbari, W Wang, PS de Vries, K Dhana, T Muka, ... Gastroenterology 153 (4), 1096-1106. e2, 2017 | 54 | 2017 |
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates W Wang, FA Lempp, F Schlund, L Walter, CC Decker, Z Zhang, Y Ni, ... Journal of hepatology 75 (2), 311-323, 2021 | 53 | 2021 |
Dynamics of proliferative and quiescent stem cells in liver homeostasis and injury W Cao, K Chen, M Bolkestein, Y Yin, MMA Verstegen, MJC Bijvelds, ... Gastroenterology 153 (4), 1133-1147, 2017 | 50 | 2017 |
6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling Y Yin, S Chen, MS Hakim, W Wang, L Xu, W Dang, C Qu, AP Verhaar, ... Antiviral research 156, 92-101, 2018 | 49 | 2018 |
IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons W Dang, L Xu, Y Yin, S Chen, W Wang, MS Hakim, KO Chang, ... Antiviral research 155, 48-59, 2018 | 49 | 2018 |
Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection X Zhou, L Xu, W Wang, K Watashi, Y Wang, D Sprengers, PE De Ruiter, ... Journal of viral hepatitis 23 (4), 294-304, 2016 | 46 | 2016 |